Clovis Oncology to Present at the 8th Annual SVB Leerink Healthcare Conference
February 22, 2019
BOULDER, Colo.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/search?q=%24CLVS&src=ctag” target=”_blank”gt;$CLVSlt;/agt;–Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that its Chief
Executive Officer and President, Patrick J. Mahaffy, will present at the
8th Annual SVB Leerink Global Healthcare Conference on Thursday,
February 28, 2019 at 11:00 a.m. Eastern time. The conference will be
held at the Lotte New York Palace in New York City.
A live webcast of the presentation and Q&A session can be accessed
through the investor relations section of the Company’s website at www.clovisoncology.com.
Following the live presentation, a replay of the webcast will be
available on the Company’s website for 30 days.
About Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company focused on
acquiring, developing and commercializing innovative anti-cancer agents
in the U.S., Europe and additional international markets. Clovis
Oncology targets development programs at specific subsets of cancer
populations, and simultaneously develops, with partners, diagnostic
tools intended to direct a compound in development to the population
that is most likely to benefit from its use. Clovis Oncology is
headquartered in Boulder, Colorado; please visit www.clovisoncology.com
for more information, including additional office locations in the U.S.
and Europe.
Contacts
Anna Sussman
303.625.5022
asussman@clovisoncology.com
Breanna Burkart
303.625.5023
bburkart@clovisoncology.com